The Vioxx recall resulted in loss of trust with lenders and a higher required return with shareholders. As a result the cost of capital increased for Vioxx. What affect does this increase have on future projects and capital investments for the company? talk about the impact of cost of capital to the financial strength of Vioxx and the consequences for stakeholders (not just shareholders) as well.?